As 2013 rapidly comes to a close, we reflect back, analyze and establish forward 2014 goals for our organization. Reflecting back provides us with more awareness of trends affecting all of us in the life-sciences industry. Consolidation and outsourcing have continued, as has increased awareness…
Do you ever feel there isn’t enough time in the day to get everything done? In the life-science industry, we are forever trying to achieve completion in time for the next site initiation visit or first patient in. Ensuring clinical trial materials are on-site in time can be…
The emergence of personalized medicine adds new complexity to patient recruitment, as clinical trial sponsors require participants to meet more granular criteria, including ethnicity. The challenge for drug development companies is to craft recruitment campaigns that educate, resonate and inspire communities of color to become…
We’ve all heard these metrics — 31 percent of Phase 2 and 30 percent of Phase 3 trials are running longer. And site staff members are over-resourced. Time delays demotivate site performance. There are three pieces to the puzzle to make clinical trials successful, including pharmaceutical/biotechnology companies,…
Having recently returned from this year’s Site Solutions Summit, it seems appropriate to share some reflections. Being on the Global Impact Partners Advisory Board for the Society for Clinical Research Sites (SCRS) provides a unique view into the planning and purpose of the summit. I can say…